Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry (Q33926194)

30 July 2017

title

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry (English)

1 reference

30 July 2017

Anne Sabers

6

0 references

Dick Lindhout

object named as

Dick Lindhout

series ordinal

5

0 references

Torbjörn Tomson

series ordinal

1

object named as

Torbjörn Tomson

1 reference

30 July 2017

7

Emilio Perucca

1 reference

30 July 2017

2

Dina Battino

1 reference

30 July 2017

3

Erminio Bonizzoni

1 reference

30 July 2017

8

Frank Vajda

1 reference

30 July 2017

John Craig

4

1 reference

30 July 2017

EURAP study group

series ordinal

9

1 reference

30 July 2017

publication date

5 June 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

10

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

609-617

1 reference

Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Pregnancy registries: differences, similarities, and possible harmonization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Valproic acid monotherapy in pregnancy and major congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Antiepileptic drug regimens and major congenital abnormalities in the offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Congenital malformations due to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Antiepileptic drug use of women with epilepsy and congenital malformations in offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Multiple imputation: current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Major malformations in offspring of women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

The AED (antiepileptic drug) pregnancy registry: a 6-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Increased rate of major malformations in offspring exposed to valproate during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Pregnancy, delivery, and outcome for the child in maternal epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Neuropsychological effects of exposure to anticonvulsant medication in utero

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

The longer term outcome of children born to mothers with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970107-7

7 January 2021

10.1016/S1474-4422(11)70107-7

Identifiers

DOI

1 reference

30 July 2017

1 reference